Jump to the main content block
 

Highlight

2025_iGEM

2025_CCU_iGEM  2025_iGEM_Gold

The iGEM competition is an international interdisciplinary student competition hosted by MIT, primarily focusing on ...

Anti-allergic drug to become a new weapon against cancer

 

A collaborative research team, comprised of CCU, Academia Sinica, National Cheng Kung University (NCKU), and Chiayi C...

Natural compounds from honeysuckle can inhibit COVID-19 variants

 

A Taiwan-based cross-institutional research team comprising our university, National Cheng Kung University, Chung Sha...

DC Chang picture
prof. Cheng-I Lee operation experiment photos
Michael Chan picture

A joint research project from CCU Biomedical Sciences and the Chia Yi Christian Hospital (CYCH) has recently discovered that cyproheptadine, an anti-histamine, exhibited anti-tumor activity. This joint research project, which was first initiated by Prof. De-Ching Chang and now by Prof Michael Chan and several other medical doctors from CYCH including Dr. CH Shen, has uncovered the role of this anti-histamine in reversing the cancer epigenome. This work was recently published in the highly regarded Oncology journal “Oncogene”.

Login Success